As of the 24th of January, Coloplast shows the Risk Adjusted Performance of (0.03), mean deviation of 0.9993, and Standard Deviation of 1.41. Coloplast A technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Coloplast's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Coloplast's valuation are provided below:Coloplast A does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Please note, there is a significant difference between Coloplast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Coloplast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coloplast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Coloplast 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Coloplast's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Coloplast.
0.00
10/26/2025
No Change 0.00
0.0
In 3 months and 1 day
01/24/2026
0.00
If you would invest 0.00 in Coloplast on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Coloplast A or generate 0.0% return on investment in Coloplast over 90 days. Coloplast is related to or competes with China Shineway, Supermax Berhad, Kaken Pharmaceutical, and Luye Pharma. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United Sta... More
Coloplast Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Coloplast's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Coloplast A upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Coloplast's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Coloplast's standard deviation. In reality, there are many statistical measures that can use Coloplast historical prices to predict the future Coloplast's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Coloplast. Your research has to be compared to or analyzed against Coloplast's peers to derive any actionable benefits. When done correctly, Coloplast's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Coloplast A.
Coloplast A secures Sharpe Ratio (or Efficiency) of -0.0662, which signifies that the company had a -0.0662 % return per unit of risk over the last 3 months. Coloplast A exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Coloplast's Standard Deviation of 1.41, mean deviation of 0.9993, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.72, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Coloplast's returns are expected to increase less than the market. However, during the bear market, the loss of holding Coloplast is expected to be smaller as well. At this point, Coloplast A has a negative expected return of -0.0957%. Please make sure to confirm Coloplast's maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Coloplast A performance from the past will be repeated at some point in the near future.
Auto-correlation
-0.25
Weak reverse predictability
Coloplast A has weak reverse predictability. Overlapping area represents the amount of predictability between Coloplast time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Coloplast A price movement. The serial correlation of -0.25 indicates that over 25.0% of current Coloplast price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.25
Spearman Rank Test
-0.24
Residual Average
0.0
Price Variance
0.03
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
In accordance with the recently published financial statements, Coloplast A has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
The Macroaxis Fundamental Analysis modules help investors analyze Coloplast A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coloplast using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coloplast A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.